By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Blueprint Medicines 

Cambridge  Massachusetts  02140  U.S.A.
Phone: 617-585-2033 Fax: n/a



Company News
Blueprint Medicines (BPMC) Appoints Lonnel Coats To Board Of Directors 2/5/2016 6:40:08 AM
Blueprint Medicines (BPMC) Strengthens Executive Leadership Team 1/6/2016 7:13:21 AM
Blueprint Medicines (BPMC) Added To NASDAQ Biotechnology Index 12/18/2015 6:43:48 AM
DiscoveRx Corporation Announces Extension Of Agreement With Blueprint Medicines (BPMC) 12/8/2015 9:16:38 AM
Blueprint Medicines (BPMC) And PatientCrossroads Launch Registry For Mastocytosis Patients To Increase Understanding Of Disease And Speed Therapeutic Development 12/1/2015 9:09:58 AM
Blueprint Medicines (BPMC) To Present Preclinical Data At 2015 American Society of Hematology Annual Meeting Demonstrating Anti-Tumor Activity Of BLU-285 In A Model Of Acute Myeloid Leukemia 11/12/2015 10:51:14 AM
Blueprint Medicines (BPMC) Reports Third Quarter 2015 Financial Results 11/10/2015 7:58:42 AM
Blueprint Medicines (BPMC) Highlights Advances In Preclinical Discovery Efforts 11/10/2015 6:40:36 AM
Blueprint Medicines (BPMC) Receives FDA Orphan Drug Designation For Novel Drug Candidate For Treatment Of Hepatocellular Carcinoma 9/30/2015 6:32:43 AM
Blueprint Medicines (BPMC) Receives FDA Authorization To Advance Novel Drug Candidate Into Clinical Trial For Systemic Mastocytosis 9/10/2015 6:29:14 AM